Search clinical trials for: Prasugrel or Clopidogrel

Total 6268 results

University of Pecs

Completed

Prasugrel Versus Clopidogrel to TREAT High Platelet Reactivity (TREAT-HPR)

Acute Coronary Syndrome

Hungary
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event (SWAP)

Acute Coronary Syndrome | Coronary Arteriosclerosis

United States
Imam Abdulrahman Bin Faisal University
King Fahad Armed Forces Hospital; Dammam Central Hospital

Unknown

Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

Myocardial Infarction | Infarction | Ischemia | Coronary Artery Disease | Cardiovascular Disease | Embolism | Thrombosis | Chest Pain | Angina Pectoris | Heart Disease | Vascular Disease

Saudi Arabia
University of Patras

Completed

Effect of Ticagrelor on Fractional Flow Reserve

Fractional Flow Reserve

Greece
Ludwig-Maximilians - University of Munich

Recruiting

Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI (EPIDAURUS)

Atrial Fibrillation | Acute Coronary Syndrome

Germany
Assistance Publique - Hôpitaux de Paris
Eli Lilly and Company; Daiichi Sankyo, Inc.; Stentys; Accumetrics, Inc.; Allies in...

Completed

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel (ANTARCTIC)

Acute Coronary Syndrome

France
W.L.Gore & Associates

Recruiting

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study (RELIEF)

Migraine | Patent Foramen Ovale | PFO - Patent Foramen Ovale

United States
University of Patras

Completed

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).

Coronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS)

Greece
St. Antonius Hospital
UMC Utrecht; Leiden University Medical Center; Medical Centre Leeuwarden; Rijnstate... and other collaborators

Unknown

Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly (POPular AGE)

Unstable Angina | Non-ST-elevation Acute Coronary Syndrome | Non-ST-elevation Myocardial Infarction

Netherlands
Kaiser Franz Josef Hospital

Completed

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry (IDEAL-PCI)

Coronary Stent Implantation | Platelet Inhibition

Austria
Brigham and Women's Hospital

Completed

Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data

Antiplatelet

United States
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Completed

A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk (RAPID MANAGE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention

Canada
Lene Holmvang

Completed

Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI (TAILOR)

Coronary Artery Disease | Percutaneous Coronary Intervention | Acute Coronary Syndromes

Denmark
Dong-A University

Completed

Prasugrel With Lower Dose - Loading Dose (PRELOAD-LD)

Coronary Artery Disease

Korea, Republic of
Eli Lilly and Company
Daiichi Sankyo, Inc.; The TIMI Study Group

Completed

Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting (PRINCIPLE)

Coronary Artery Disease

France, United States, Israel, Germany
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients (PANDDA)

Diabetes

Canada
Samsung Medical Center

Unknown

Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE) (SMART-DATE)

Acute Coronary Syndrome

Korea, Republic of
Jules Desmeules

Terminated

Impact of Antiretroviral Treatment on Pharmacokinetics and Pharmacodynamics of Thienopyridines in Healthy Volunteers and HIV Patients (IMPACT/R)

Hiv

Switzerland
Eli Lilly and Company

Completed

A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Heart Diseases | Cardiovascular Diseases

United States, Canada
Faculty Hospital Kralovske Vinohrady

Completed

The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry (LAPCOR)

Platelet Aggregation Onhibitors

Czechia
University of Maryland, Baltimore
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study (PAPI-2)

Cardiovascular Diseases | Acute Coronary Syndrome

United States
University of Nebraska
Eli Lilly and Company; Daiichi Sankyo, Inc.

Completed

Platelet Inhibition in Patients With Systolic Heart Failure

Systolic Heart Failure

United States
Yonsei University
Gangnam Severance Hospital; Severance Hospital; Bucheon St. Mary's Hospital; International... and other collaborators

Recruiting

Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm

Intracranial Aneurysm

Korea, Republic of
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease (GENERATIONS)

Coronary Artery Disease

Netherlands, Sweden, United States, Ireland
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease (FEATHER)

Coronary Artery Disease

Sweden, Netherlands, United States, Ireland
University of Patras

Completed

Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI) (PRO-GR-4)

Myocardial Infarction

Greece
University of Patras

Completed

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis

Hemodialysis | Chronic Renal Failure

Greece
University of Patras

Completed

Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment

Coronary Artery Disease (CAD)

Greece
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Terminated

Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

Acute Coronary Syndromes

Germany
Assistance Publique Hopitaux De Marseille

Completed

Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

Acute Coronary Syndromes

France
Gennaro Sardella

Completed

Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial (RESET GENE)

Acute Coronary Syndrome

Italy
St. Francis Hospital, New York

Unknown

Plavix, Prasugrel and Drug Eluting Stents Pilot Trial (PPD)

Coronary Artery Disease | Platelet Aggregation Inhibitors | PCI- Percutaneous Coronary Intervention

United States
University of Patras

Completed

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

Platelet Reactivity

Greece
Medical University of Vienna

Unknown

High "on Treatment" Platelet Reactivity in the Intensive Care Unit

Critical Illness

Austria
Indiana University

Terminated

Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)

Coronary Artery Disease | Thrombosis

United States
Gennaro Sardella

Unknown

Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary Syndrome (RESET ELDERLY)

Coronary Artery Disease

Italy
Chiang Mai University

Unknown

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

Antiplatelet Agents | Dental Diseases | Antiplatelet Drugs
University of Roma La Sapienza

Completed

High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients (TRIPLETE RESET)

Coronary Artery Disease

Italy
Eli Lilly and Company

Completed

Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients

Acute Coronary Syndrome

India
Royal Brompton & Harefield NHS Foundation Trust
University Hospital Tuebingen

Terminated

Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention (APACS-HPR)

Cardiovascular Disease | Acute Coronary Syndrome

Germany
St. Antonius Hospital
St. Antonius hospital Onderzoeksfonds; Ace pharmaceuticals; Allgen pharmaceuticals

Recruiting

Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease (BW-ACCORD)

Coronary Artery Disease | Platelet Reactivity

Netherlands
The Medicines Company

Completed

Cangrelor to Clopidogrel or Prasugrel Transition Study (BRIDGE)

Coronary Artery Disease (CAD)

United States
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3) (OPTIMUS-3)

Coronary Artery Disease | Diabetes Mellitus

United States
Eli Lilly and Company
Daiichi Sankyo, Inc.

Completed

A Study of Prasugrel in Healthy Participants

Healthy Volunteers

United States
Maasstad Hospital
Daiichi Sankyo, Inc.; MicroPort Orthopedics Inc.; Research Maatschap Cardiologen...

Completed

CRUSHed vs. Uncrushed Prasugrel in STEMI Patients Undergoing PCI (CompareCrush)

Cardiovascular Diseases

Netherlands
Aggredyne, Inc.

Completed

Study of AggreGuide A-100 (ADP) Assay

Risk Factor, Cardiovascular | Platelet Dysfunction Due to Drugs
University of Florida

Recruiting

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI (TAILOR BLEED)

Coronary Artery Disease

United States
The Royal Wolverhampton Hospitals NHS Trust

Completed

P3AMI Antiplatelet Trial

Heart Attack

United Kingdom
Tufts Medical Center

Completed

Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation

Coronary Artery Disease

United States
Arcispedale Santa Maria Nuova-IRCCS
Italian Society of Invasive Cardiology; ANMCO Italian Association of Hospital...

Unknown

The Elderly ACS II Trial

Myocardial Ischemia | Cardiovascular Diseases | Acute Coronary Syndrome | Coronary Arteriosclerosis

Italy

Search clinical trials for: Prasugrel or Clopidogrel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations